Sentences with phrase «diagnostic development with»

Not exact matches

«It essentially gives us a periodic table,» Ron DePinho, President of MD Anderson Cancer Center says, which has provided us with both diagnostic and therapeutic value as well as helped us design clinical trials to accelerate the development of new cancer drugs,».

The result will be building blocks for industry with the development of new technologies including biomaterials (proteins) from insects and other invertebrates, along with sensory and diagnostic platforms with industrial and environmental applications.

Support for translational research has helped with the development of new drugs, diagnostics and vaccines, Hotez says, but funding for basic research has lagged behind.

Eric Rubin, a microbiologist at Harvard School of Public Health in Boston, Massachusetts, says that although the probe still requires clinical testing, «a diagnostic based on this principle could make a big impact both in drug development and in controlling disease, especially in areas with limited access to technology».

The researchers, who have since spun off MiRXES, a biotechnology startup, are now working with the Singapore Gastric Cancer Consortium and the A * STAR Diagnostic Development Hub to develop a test that detects gastric cancer before symptoms appear.

As early as 1969, these collaborations led to important products - directly, as with the development of diagnostics for drugs of abuse, Abuscreen; or indirectly, through the development of technologies, which later played a key role in the first isolation and characterization of the a-interferons and to Roche's patents for Roferon.

For this survey of global health, Science has joined forces with Science Translational Medicine, which examines vaccine development, strategies against emerging infections, progress in point - of - care diagnostics, and ways to promote mental health and neonatal health.

Researchers at Lund University in Sweden have now produced images showing the changes in the brain associated with these symptoms — a development which increases knowledge and could facilitate future diagnostics and treatment.

With the development of early diagnostics of the disease, the question of which treatments to offer to completely healthy people with an increased risk of developing Alzheimer's becomes of key importance in the field of medicWith the development of early diagnostics of the disease, the question of which treatments to offer to completely healthy people with an increased risk of developing Alzheimer's becomes of key importance in the field of medicwith an increased risk of developing Alzheimer's becomes of key importance in the field of medicine.

Current methods associated with epigenetics research will be discussed, as well as how these technologies are advancing the development of new diagnostics and biomarkers.

Interestingly, genomic analyses suggested that ESCC and head and neck squamous cell carcinoma (HNSCC) shared some common pathogenic mechanisms, and ESCC development is associated with alcohol drinking.These findings would provide a brand - new insight into the understandings of ESCC tumorigenesis, and would help clinicians to develop more effective diagnostic and therapeutic approaches for ESCC.

As this variant also appears to be associated with the development of more aggressive prostate tumors, a diagnostic test for the variant may enable doctors to make more informed decisions as to how closely they should monitor those who are at high risk, and how aggressively they should treat the disease once it presents.

By bringing together multi-disciplinary expertise, facilities and patient resources to support the development of promising drugs and diagnostics, EATRIS accelerates and de-risks the path to clinical proof of concept and partners with key stakeholders for the validation and introduction of novel tools to support R&D.

Ludwig combines basic research with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies.

These risks and uncertainties include, among others, those relating to our ability to obtain financing and to form collaborative relationships, uncertainty regarding potential future deterioration in the market for auction rate securities which could result in additional permanent impairment charges, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.

«Having been a partner with Roche for several years, we have every confidence that the combination of our own expertise and Roche's considerable capabilities in clinical development, biomarkers and diagnostics will help us maximize the potential for this programme,» commented Stuart W. Peltz, Ph.D., President and CEO of PTC.

In vitro diagnostics (IVD) is one of the areas of biomedicine and, in general, biotechnology, with the highest rates of international development.

Our staff can provide support for diagnostic tool development with a wide array of platforms including bead - based technologies.

The collaborations between the funding agencies and between the researchers will result in an accelerated development of diagnostic tools and therapies for people with a rare disease.

These risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.

In recent years this partnership has resulted in the development of several pieces of diagnostic and medical - assistant technology, with medical experts on the Emory side working with engineers on the Georgia Tech side.

This department provides clinicians and researchers with human and technological resources enabling the development of application - oriented projects, with the objective of improving care for cancer patients (assessment and validation of diagnostic, prognostic and patient support tools, as well as development of biomedical devices or therapeutic approaches resulting from basic research).

The operationalization of mild cognitive impairment (MCI) led to targeting earlier symptomatic cases of the illness and treatment strategies based less on pathology and more on a chance to halt or slow decline than there would be earlier in the disease.1 With the development of amyloid imaging, MCI due to AD diagnosis was refined, 2 and early - stage AD was extended further to include preclinical AD, 3 wherein a positive amyloid positron emission tomography (PET) scan or diagnostic low levels of cerebrospinal fluid β - amyloid (Aβ) indicated the presence of pathology in people who were cognitively normal.

These risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, the outcome of the review of the continued listing of our common stock on The Nasdaq Stock Market, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.

However, for the majority targeted therapies in development — and their combinations with current standard therapies — there are still no approved diagnostic tools to determine which patients are most likely to benefit from or be resistant to these novel agents or drug combinations.

In addition, the company collaborates with biopharmaceutical companies in the development of companion diagnostic tests and technologies for various cancer therapies, helping to realize the promise of precision oncology.

SAN DIEGO, March 28, 2017 (GLOBE NEWSWIRE)-- Invivoscribe ® Technologies Inc., a global company with decades of experience providing internationally standardized clonality and biomarker testing solutions for the fields of oncology, personalized molecular diagnostics ®, and personalized molecular medicine ®, reports that its next - generation sequencing (NGS) LymphoTrack ® Assay kits are being used by its LabPMM ® clinical laboratories, pharmaceutical partners, and cancer centers to identify and monitor chimeric antigen receptor T - cells (CAR - T) and engineered T - cell receptors in peripheral blood of subjects in support of immuno - therapeutic drug development and treatment regimen development for both hematologic and solid tumors.

With ~ 81 % of the human proteome on a single slide, ImmuneProfiler represents a more comprehensive and high - throughput alternative to other assay platforms for the development of predictive early diagnostic tests.

Accelerate the development of novel diagnostics and therapeutics for the treatment of lymphoid cancers by fostering a cutting - edge multi-disciplinary research environment with a focus on clinical applications.

Although next - generation sequencing has revolutionized the ability to associate variants with human diseases, diagnostic rates and development of new therapies are still limited by a lack of knowledge of the functions and pathobiological mechanisms of most genes.

The A4M promotes the research of practices and protocols that collectively have the potential to optimize the human aging process, with the development of therapeutic protocols and innovative diagnostic tools that can effectively spur longevity treatments.

The program builds on the outcomes and competencies of the Master of Oriental Medicine program with the addition of 28 doctoral - specific competencies in the domains of research literacy, advanced diagnostic studies, systems - based medicine, and professional development, along with an enhanced clinical training.

Then, when the twins reached age 18, the twins were interviewed and assessed for ADHD — defined by Diagnostic and Statistical Manual of Mental Disorders as «a persistent pattern of inattention and / or hyperactivity - impulsivity that interferes with functioning or development in two or more settings.»

The data from the diagnostic feeds into an online platform, which provides students with work in their zone of proximal development.

The members of this camp praise national standards, a national (or at least statewide) curriculum that gathers the best thinking about how to reach these standards and shares this thinking with the teaching corps, authentic assessments that provide diagnostic information, and professional development (pre-service and in - service) that is seamlessly woven into all of the rest.

With particular emphasis on the increased mathematical demands of the 2015 AQA, OCR and Pearson Edexcel teaching specifications, this multimedia data handling teaching resource provides an overview of TB and drug - resistant TB (DR - TB) including risk factors of developing TB, available vaccines and treatments, current research and development of both drugs and diagnostic tools.

A few talked about the development of diagnostic and formative assessments, aligned with state and district curriculum standards, used by teachers to track student performance.

Whether with or without diagnostic data, Problem Analysis leads to Plan Development.

If you decide to earn a degree in special education, your curriculum may include classes like Instructional Planning in Special Education, Teaching Mathematics to Learners with Special Needs, Diagnostic Assessment, Classroom Management, and Curriculum Development for Special Education.

Measures to improve professionalism in teaching with particular regard to diagnostic and methodical competence as an element of systematic school development.

Alongside its development of exhaust gas cleaning technology, Honda also plans to address other technical challenges in developing clean diesel engines, such as handling diesel fuels with different cetane numbers (a problem in some markets) and meeting US On - Board Diagnostic System requirements.

Biogal is headquartered in Israel and was established in 1986 with a focus on the development, manufacturing and marketing of diagnostic tools for the veterinary industry.

New FluSure XP, when used with FluSure ® Pandemic as part of the FluSure XP Defense System ™, helps guard against 9 out of 10 of the most current flu strains that threaten swine herds today.8 The FluSure XP Defense System also includes SIV surveillance, diagnostics, research and development, and manufacturing support from Pfizer Animal Health.

Dr. Forman is actively involved with academia and industry in the development of diagnostic tools for pancreatitis.

Greenfield (IN), U.S., 20th March 2018 - Elanco Animal Health, together with the COAST Development Group, today announce the publication of a proposal for a practical diagnostic aid, called «COAST» (Canine OsteoArthritis Staging Tool)-- A tool expected to improve the diagnosis and monitoring of dogs with osteoarthritis with the potential to guide disease management plans.

In fact, they are collaborating with top developers and researchers in the country to make even more advances in diagnostic testing procedures and technology so that cats everywhere — not just here in Castle Rock — can benefit from these exciting developments in laboratory services.

Programs with research emphasis on signal transduction in development and oncogenesis, cell adhesion molecules in development and oncogenesis, muscologskeletal atrophy and countermeasures, ovarian follicle development, neural regeneration, implantable therapeutic or diagnostic devices and application of computers in veterinary education.

With the advent of genome - wide sequencing technologies and the increasing development of new diagnostic DNA disease tests, the full extent and prevalence of inherited disorders in pedigree dogs is now being realized.

Emergency Room Physician — Advocate Healthcare Lakeview, Chicago IL — 5/2010 — Present • Treat patients entering the emergency room by observing behavior, providing physical assessments, and documenting changes in the patient's condition • Collaborate with other physicians and nursing staff, listening to feedback as well as providing professional advice • Order appropriate diagnostic tests based off assessments • Research developments in emergency care and communicate relevant information to providers and staff • Create a treatment plan based off consultations, medication history, and best practice guidelines

HEWLETT PACKARD, San Diego, CA 02/1981 — 08/2007 Research and Development Associate / Assembly Line and Diagnostic Testing Inspector Collaborated with engineering teams to test and perform troubleshooting for product dDevelopment Associate / Assembly Line and Diagnostic Testing Inspector Collaborated with engineering teams to test and perform troubleshooting for product developmentdevelopment.